A1ESQ

Crisugabalin

Created:	2025-06-29
Last modified:	2026-01-07

Find Related PDB Entry
1 entries where A1ESQ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	5
Bond Count	36
Aromatic Bond Count	0

2D diagram of A1ESQ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Crisugabalin
Formula	C₁₂ H₁₉ N O₂
Molecular Weight	209.285
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	NC[C]1(CC(O)=O)[CH]2CC[CH]3C[CH]2[CH]1C3
SMILES	OpenEye OEToolkits	2.0.7	C1CC2C3CC1CC3C2(CC(=O)O)CN
Canonical SMILES	CACTVS	3.385	NC[C@@]1(CC(O)=O)[C@@H]2CC[C@H]3C[C@@H]2[C@@H]1C3
Canonical SMILES	OpenEye OEToolkits	2.0.7	C1C[C@@H]2[C@@H]3C[C@H]1C[C@@H]3[C@@]2(CC(=O)O)CN
InChI	InChI	1.06	InChI=1S/C12H19NO2/c13-6-12(5-11(14)15)9-2-1-7-3-8(9)10(12)4-7/h7-10H,1-6,13H2,(H,14,15)/t7-,8-,9+,10-,12-/m0/s1
InChIKey	InChI	1.06	WCEFMBSFXJUREW-LIJGXYGRSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB19300
Name	Crisugabalin
Groups	investigational
Description	Crisugabalin is under investigation in clinical trial NCT06490484 (Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin).
Synonyms	Crisugabalin
CAS number	2209104-84-5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.